Cardiac troponin I in breast cancer patients receiving anthracycline chemotherapy

被引：0
|
作者：
Bauer-Kosinska, B
Miskiewicz, ZC
Kaminska, J
Kowalska, M
Pienkowski, T
机构：
[1] Maria Sklodowska Curie Mem Canc Ctr, Breast Canc Dept, Warsaw, Poland
[2] Maria Sklodowska Curie Mem Canc Ctr, Dept Radiol, Warsaw, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷
关键词：
D O I：
10.1016/S0959-8049(02)80443-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
357
引用
收藏
页码：S135 / S135
页数：1
相关论文
共 50 条
  • [1] Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review
    Simoes, Ricardo
    Silva, Luciana Maria
    Valle Mussi Cruz, Andre Luiz
    Fraga, Vanessa Gomes
    Sabino, Adriano de Paula
    Gomes, Karina Braga
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 107 : 989 - 996
  • [2] Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
    Blaes, Anne H.
    Rehman, Aamer
    Vock, David M.
    Luo, Xianghua
    Menge, Mark
    Yee, Douglas
    Missov, Emil
    Duprez, Daniel
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 591 - 594
  • [3] Evaluation of ultrasensitive cardiac Troponin I levels in patients with breast cancer during chemotherapy
    Moreno, Ricardo
    Costa, Renata G.
    Mazar, Renata C.
    Silva, Mayra B.
    de Souza, Mariana G.
    Murad, Neif
    Feder, David
    Azzalis, Ligia A.
    Alves, Beatriz C. A.
    Gehrke, Flavia S.
    Adami, Fernando
    Fonseca, Fernando L. A.
    CLINICA CHIMICA ACTA, 2014, 428 : 70 - 71
  • [4] Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer
    Nawa-Nishigaki, Minako
    Kobayashi, Ryo
    Suzuki, Akio
    Hirose, Chiemi
    Matsuoka, Rie
    Mori, Ryutaro
    Futamura, Manabu
    Sugiyama, Tadashi
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    ANTICANCER RESEARCH, 2018, 38 (02) : 877 - 884
  • [5] Emesis control in patients receiving adjuvant IVCMF or anthracycline chemotherapy for breast cancer
    Anderson, A
    Ellis, K
    Douglas, SL
    Cameron, DA
    Leonard, RCF
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S378 - S378
  • [6] Prognostic value of troponin I for chemotherapy-induced cardiac dysfunction in breast cancer patients
    Adachi, Y.
    Yoshimura, A.
    Ichikawa, M.
    Ishiguro, J.
    Kotani, H.
    Hisada, T.
    Hattori, M.
    Kondou, N.
    Sawaki, M.
    Iwata, H.
    BREAST, 2015, 24 : S72 - S73
  • [7] Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy
    Smith, K. L.
    Griffin, J. M.
    Tsai, H-L
    Leathers, M.
    Hays, A.
    Lu, D-Y
    Zhang, Z.
    Rosner, G. L.
    Russell, S. D.
    Connolly, R. M.
    Jelovac, D.
    Visvanathan, K.
    Wolff, A. C.
    Stearns, V.
    Abraham, T.
    CANCER RESEARCH, 2019, 79 (04)
  • [8] Longitudinal High-Sensitivity Cardiac Troponin I Measurements in Patients With Breast Cancer Receiving Trastuzumab
    Dhesy-Thind, Sukhbinder
    Ellis, Peter M.
    Mukherjee, Som D.
    Mackett, Katharine
    Bordeleau, Louise
    Kavsak, Peter A.
    CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (04)
  • [9] Cardiovascular status of breast cancer patients before and after receiving anthracycline chemotherapy regimen
    Dong, Zhaoying
    Liu, Zhaojun
    Chen, Siyu
    Zhang, Changhong
    Xiao, Jun
    Zhou, Xiaoli
    NURSING OPEN, 2022, 9 (01): : 256 - 266
  • [10] Hepatotoxicity of anthracycline chemotherapy in patients with breast cancer
    Guskova, Nailya
    Kit, Oleg I.
    Vladimirova, Liubov Yu
    Tikhanovskaya, Natalya Mikhailovna
    Sycheva, Elena A.
    Nozdricheva, Anastasia
    Abakumova, Svetlana V.
    Abramova, Natalya A.
    Storozhakova, Anna E.
    Popova, Irina L.
    Ryadinskaya, Ludmila A.
    Lyanova, Aza A.
    Novoselova, Kristina A.
    Lisunova, Zinaida P.
    Avanesova, Kristina
    Zekhtser, Ineya I.
    Belgova, Svetlana V.
    Zakharchenko, Viktoria
    Tselishcheva, Irina V.
    Torpudzhyan, Izabella
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345